Technologies Available for Licensing

Technology Transfer Update
Receive email updates about current licensing opportunities.
Learn more

Memorial Sloan Kettering is developing an extensive assortment of technologies with applications for oncology and many other areas of healthcare and science. We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.

Explore our list of technologies available for licensing below, and filter by technology categories.

Some of our newest technologies may not appear in this list. To learn about recent developments, contact any member of our staff about your particular interests.

33 Technologies found
SK2022-123
On-demand TNFRSF CD200R & PD1 Switch Receptors
With applicability to both approved hematologic products and emerging solid tumor programs, multi-switch receptor arrays offer a platform solution to enhance virtually any CAR T-cell therapy encountering tumor-mediated immune suppression.
SK2021-083
Pan-Cancer Reactive NDC80 CAR
SK2021-008
PRAME TCR Mimic (mTCR) Antibody and CAR T-Cell Therapy
This MSK technology is a cancer-testis antigen with restricted expression in normal tissues but broad overexpression across multiple cancer types, making it an ideal target for cancer immunotherapy.